CN102824563B - 一种治疗尿频尿急型闭合性骨折的中药洗剂制备方法 - Google Patents
一种治疗尿频尿急型闭合性骨折的中药洗剂制备方法 Download PDFInfo
- Publication number
- CN102824563B CN102824563B CN 201210305151 CN201210305151A CN102824563B CN 102824563 B CN102824563 B CN 102824563B CN 201210305151 CN201210305151 CN 201210305151 CN 201210305151 A CN201210305151 A CN 201210305151A CN 102824563 B CN102824563 B CN 102824563B
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- herb
- micturition
- closed fracture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000027939 micturition Effects 0.000 title claims abstract description 30
- 208000003044 Closed Fractures Diseases 0.000 title claims abstract description 23
- 239000006210 lotion Substances 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 29
- 238000011282 treatment Methods 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 235000009797 Lagenaria vulgaris Nutrition 0.000 claims abstract description 7
- 241001116755 Selliguea Species 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 229940126678 chinese medicines Drugs 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 210000002700 urine Anatomy 0.000 claims description 7
- 235000005983 Crescentia cujete Nutrition 0.000 claims description 6
- 241000222640 Polyporus Species 0.000 claims description 6
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 6
- 240000009087 Crescentia cujete Species 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000722953 Akebia Species 0.000 abstract 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000036905 Benincasa cerifera Species 0.000 abstract 1
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract 1
- 244000104272 Bidens pilosa Species 0.000 abstract 1
- 235000010662 Bidens pilosa Nutrition 0.000 abstract 1
- 241000405421 Breynia Species 0.000 abstract 1
- 235000011305 Capsella bursa pastoris Nutrition 0.000 abstract 1
- 240000008867 Capsella bursa-pastoris Species 0.000 abstract 1
- 241000530402 Changium Species 0.000 abstract 1
- 241000233839 Commelina communis Species 0.000 abstract 1
- 244000068485 Convallaria majalis Species 0.000 abstract 1
- 235000009046 Convallaria majalis Nutrition 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 241000466334 Hemsleya macrosperma Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 244000303847 Lagenaria vulgaris Species 0.000 abstract 1
- 241000522169 Lespedeza Species 0.000 abstract 1
- 241001633628 Lycoris Species 0.000 abstract 1
- 244000187664 Nerium oleander Species 0.000 abstract 1
- 241000304370 Orostachys Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 240000005319 Sedum acre Species 0.000 abstract 1
- 235000014327 Sedum acre Nutrition 0.000 abstract 1
- 241000133430 Tinospora Species 0.000 abstract 1
- 241001530121 Trollius Species 0.000 abstract 1
- 244000089698 Zanthoxylum simulans Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- IWBJJCOKGLUQIZ-HQKKAZOISA-N hyperforin Chemical compound OC1=C(CC=C(C)C)C(=O)[C@@]2(CC=C(C)C)C[C@H](CC=C(C)C)[C@](CCC=C(C)C)(C)[C@]1(C(=O)C(C)C)C2=O IWBJJCOKGLUQIZ-HQKKAZOISA-N 0.000 abstract 1
- QOVWXXKVLJOKNW-UHFFFAOYSA-N hyperforin Natural products CC(C)C(=O)C12CC(CC=C(C)C)(CC(CC=C(C)C)C1CCC=C(C)C)C(=C(CC=C(C)C)C2=O)O QOVWXXKVLJOKNW-UHFFFAOYSA-N 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 description 25
- 210000004072 lung Anatomy 0.000 description 21
- 239000003440 toxic substance Substances 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 20
- 208000004880 Polyuria Diseases 0.000 description 19
- 230000035619 diuresis Effects 0.000 description 19
- 235000009508 confectionery Nutrition 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- 206010017076 Fracture Diseases 0.000 description 14
- 208000010392 Bone Fractures Diseases 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 230000001939 inductive effect Effects 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- 230000023597 hemostasis Effects 0.000 description 10
- 210000003932 urinary bladder Anatomy 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 210000002429 large intestine Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000011708 Avulsion fracture Diseases 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 244000174681 Michelia champaca Species 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 229960002233 benzalkonium bromide Drugs 0.000 description 1
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229960001991 ceftizoxime Drugs 0.000 description 1
- NNULBSISHYWZJU-LLKWHZGFSA-N ceftizoxime Chemical compound N([C@@H]1C(N2C(=CCS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 NNULBSISHYWZJU-LLKWHZGFSA-N 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
| 年龄(岁) | 23~30 | 31~40 | 41~50 | 51~60 |
| 例数 | 11 | 252 | 116 | 9 |
| 百分比 | 2.8% | 65% | 29.9% | 2.3% |
| 疗效 | 治愈 | 好转 | 无效 |
| 例数 | 386 | 2 | 无 |
| 百分比 | 99.5% | 0.5% | 无 |
| 治疗天数 | 3~5 | 6~9 | 10~15 | 16~26 |
| 例数 | 13 | 246 | 122 | 7 |
| 百分比 | 3.4% | 63.4% | 31.4% | 1.8% |
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210305151 CN102824563B (zh) | 2012-08-27 | 2012-08-27 | 一种治疗尿频尿急型闭合性骨折的中药洗剂制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210305151 CN102824563B (zh) | 2012-08-27 | 2012-08-27 | 一种治疗尿频尿急型闭合性骨折的中药洗剂制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102824563A CN102824563A (zh) | 2012-12-19 |
| CN102824563B true CN102824563B (zh) | 2013-11-06 |
Family
ID=47328009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210305151 Expired - Fee Related CN102824563B (zh) | 2012-08-27 | 2012-08-27 | 一种治疗尿频尿急型闭合性骨折的中药洗剂制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102824563B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824560A (zh) * | 2012-08-27 | 2012-12-19 | 靳先玲 | 一种治疗心虚胆怯型闭合性骨折的中药洗剂制备方法 |
| CN103432446A (zh) * | 2013-08-18 | 2013-12-11 | 李红 | 一种治疗溲赤型根尖周炎的中药制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1698744A (zh) * | 2005-05-26 | 2005-11-23 | 谢勇志 | 速效接骨散 |
| CN1879856A (zh) * | 2006-05-01 | 2006-12-20 | 杨树民 | 一种外敷膏药 |
| CN101337059A (zh) * | 2007-07-06 | 2009-01-07 | 贾清学 | 一种治疗骨质增生的膏药及其制备方法 |
-
2012
- 2012-08-27 CN CN 201210305151 patent/CN102824563B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1698744A (zh) * | 2005-05-26 | 2005-11-23 | 谢勇志 | 速效接骨散 |
| CN1879856A (zh) * | 2006-05-01 | 2006-12-20 | 杨树民 | 一种外敷膏药 |
| CN101337059A (zh) * | 2007-07-06 | 2009-01-07 | 贾清学 | 一种治疗骨质增生的膏药及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102824563A (zh) | 2012-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102793852B (zh) | 一种治疗发热型闭合性骨折的中药洗剂制备方法 | |
| CN102824570B (zh) | 一种治疗溲赤型闭合性骨折的中药洗剂制备方法 | |
| CN102824563B (zh) | 一种治疗尿频尿急型闭合性骨折的中药洗剂制备方法 | |
| CN102824622B (zh) | 一种治疗心悸型闭合性骨折的中药洗剂制备方法 | |
| CN102793904B (zh) | 一种治疗烦乱型闭合性骨折的中药洗剂制备方法 | |
| CN102813853B (zh) | 一种治疗热毒型闭合性骨折的中药洗剂制备方法 | |
| CN102824421B (zh) | 一种治疗惊惕型闭合性骨折的中药洗剂制备方法 | |
| CN102793868B (zh) | 一种治疗喘促型闭合性骨折的中药洗剂制备方法 | |
| CN102824558B (zh) | 一种治疗呕吐型闭合性骨折的中药洗剂制备方法 | |
| CN102824590B (zh) | 一种治疗呼吸作痛型闭合性骨折的中药洗剂制备方法 | |
| CN102824523B (zh) | 一种治疗头痛型闭合性骨折的中药洗剂制备方法 | |
| CN102824538B (zh) | 一种治疗胃热型闭合性骨折的中药洗剂制备方法 | |
| CN102824561B (zh) | 一种治疗酗酒型闭合性骨折的中药洗剂制备方法 | |
| CN102793853B (zh) | 一种治疗便秘型闭合性骨折的中药洗剂制备方法 | |
| CN102824556B (zh) | 一种治疗痰浊壅塞型闭合性骨折的中药洗剂制备方法 | |
| CN102824571B (zh) | 一种治疗嗜食辣椒型闭合性骨折的中药洗剂制备方法 | |
| CN102824584B (zh) | 一种治疗嗜饮浓茶型闭合性骨折的中药洗剂制备方法 | |
| CN102824554B (zh) | 一种治疗口渴型闭合性骨折的中药洗剂制备方法 | |
| CN102824555B (zh) | 一种治疗嗜食大蒜型闭合性骨折的中药洗剂制备方法 | |
| CN102824546B (zh) | 一种治疗肾阴亏虚型闭合性骨折的中药洗剂制备方法 | |
| CN102793831B (zh) | 一种治疗高血压型闭合性骨折的中药洗剂制备方法 | |
| CN102824540B (zh) | 一种治疗血虚型闭合性骨折的中药洗剂制备方法 | |
| CN102824604B (zh) | 一种治疗经络郁滞型闭合性骨折的中药洗剂制备方法 | |
| CN102793893B (zh) | 一种治疗肝郁化火型闭合性骨折的中药洗剂制备方法 | |
| CN102824562B (zh) | 一种治疗吸烟型闭合性骨折的中药洗剂制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU AIPING Free format text: FORMER OWNER: DAN SHUXIANG Effective date: 20130926 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Aiping Inventor after: Wang Qing Inventor before: Dan Shuxiang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: DAN SHUXIANG TO: LIU AIPING WANG QING Free format text: CORRECT: ADDRESS; FROM: 250013 JINAN, SHANDONG PROVINCE TO: 250200 JINAN, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130926 Address after: 250200 Zhangqiu people's Hospital, Ji'nan, Shandong Applicant after: Liu Aiping Address before: 46 Shandong Chest Hospital, Lixia mountain road, Lixia District, Shandong, Ji'nan 250013, China Applicant before: Dan Shuxiang |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 Termination date: 20140827 |
|
| EXPY | Termination of patent right or utility model |
